06/04 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Recro Pharma, Inc.
To join this class action, please complete the following Investor Certification. Oklahoma City, OK (June 4, 2018) – On May 31, 2018, a securities class action lawsuit was filed in the United States District Court for the Eastern District of Pennsylvania against Recro Pharma, Inc. (NASDAQ: REPH). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is […]